The abstract is read at the publisher; the summary is JClub's.
In nonvalvular atrial fibrillation, percutaneous left atrial appendage closure (LAAC) shows similar overall stroke rates versus oral anticoagulation (OR 1.10, 95% CI 0.78–1.56).
- Why it matters: Stroke prevention and bleeding tradeoffs remain uncertain across patient bleeding risk levels, especially after newer randomized LAAC trials expanded the evidence base.
- What they did: A systematic review and meta-analysis of 6 randomized trials (7028 patients; 358 sites in North America, Europe, and Asia) pooled cumulative-incidence outcomes with random-effects odds ratios and prespecified subgroups.
- The result: LAAC reduces nonprocedural bleeding (OR 0.58, 95% CI 0.35–0.96) in standard-risk and postablation groups, while ischemic stroke is higher (OR 1.41, 95% CI 1.07–1.86) without reaching required information size.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.